Medical societies, patient education initiatives, public debate and marketing of unproven stem cell interventions

Daniel J. Weiss; Leigh Turner; Aaron D. Levine; Laertis Ikonomou

doi:10.1016/j.jcyt.2017.10.002

Medical societies, patient education initiatives, public debate and marketing of unproven stem cell interventions

Daniel J. Weiss
, Leigh Turner
, Aaron D. Levine
, Laertis Ikonomou^*

^*Autor correspondiente de este trabajo

University of Vermont
International Society for Cellular Therapy Presidential Task Force on the Use of Unproven Cellular Therapies
School of Public Health
Georgia Institute of Technology
Boston Medical Center

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

21 Citas (Scopus)

Resumen

Businesses marketing unproven stem cell interventions proliferate within the U.S. and in the larger global marketplace. There have been global efforts by scientists, patient advocacy groups, bioethicists, and public policy experts to counteract the uncontrolled and premature commercialization of stem cell interventions. In this commentary, we posit that medical societies and associations of health care professionals have a particular responsibility to be an active partner in such efforts.

Idioma original	Inglés
Páginas (desde-hasta)	165-168
Número de páginas	4
Publicación	Cytotherapy
Volumen	20
N.º	2
DOI	https://doi.org/10.1016/j.jcyt.2017.10.002
Estado	Publicada - feb 2018
Publicado de forma externa	Sí

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

ODS 3: Salud y bienestar

Acceder al documento

10.1016/j.jcyt.2017.10.002

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

@article{cc722bf29c2c47bb9542fe54845f5657,

title = "Medical societies, patient education initiatives, public debate and marketing of unproven stem cell interventions",

abstract = "Businesses marketing unproven stem cell interventions proliferate within the U.S. and in the larger global marketplace. There have been global efforts by scientists, patient advocacy groups, bioethicists, and public policy experts to counteract the uncontrolled and premature commercialization of stem cell interventions. In this commentary, we posit that medical societies and associations of health care professionals have a particular responsibility to be an active partner in such efforts.",

keywords = "health care professionals, medical societies, patients, unproven stem cell interventions, “stem cell” clinics",

author = "Weiss, \{Daniel J.\} and Leigh Turner and Levine, \{Aaron D.\} and Laertis Ikonomou",

note = "Publisher Copyright: {\textcopyright} 2017 International Society for Cellular Therapy",

year = "2018",

month = feb,

doi = "10.1016/j.jcyt.2017.10.002",

language = "Ingl{\'e}s",

volume = "20",

pages = "165--168",

journal = "Cytotherapy",

issn = "1465-3249",

publisher = "Elsevier B.V.",

number = "2",

}

TY - JOUR

T1 - Medical societies, patient education initiatives, public debate and marketing of unproven stem cell interventions

AU - Weiss, Daniel J.

AU - Turner, Leigh

AU - Levine, Aaron D.

AU - Ikonomou, Laertis

PY - 2018/2

Y1 - 2018/2

N2 - Businesses marketing unproven stem cell interventions proliferate within the U.S. and in the larger global marketplace. There have been global efforts by scientists, patient advocacy groups, bioethicists, and public policy experts to counteract the uncontrolled and premature commercialization of stem cell interventions. In this commentary, we posit that medical societies and associations of health care professionals have a particular responsibility to be an active partner in such efforts.

AB - Businesses marketing unproven stem cell interventions proliferate within the U.S. and in the larger global marketplace. There have been global efforts by scientists, patient advocacy groups, bioethicists, and public policy experts to counteract the uncontrolled and premature commercialization of stem cell interventions. In this commentary, we posit that medical societies and associations of health care professionals have a particular responsibility to be an active partner in such efforts.

KW - health care professionals

KW - medical societies

KW - patients

KW - unproven stem cell interventions

KW - “stem cell” clinics

UR - https://www.scopus.com/pages/publications/85035124507

U2 - 10.1016/j.jcyt.2017.10.002

DO - 10.1016/j.jcyt.2017.10.002

M3 - Artículo

C2 - 29239793

AN - SCOPUS:85035124507

SN - 1465-3249

VL - 20

SP - 165

EP - 168

JO - Cytotherapy

JF - Cytotherapy

IS - 2

ER -

Medical societies, patient education initiatives, public debate and marketing of unproven stem cell interventions

Resumen

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto